Ernexa Therapeutics Inc. (ERNA): Revenue
$582.0K
Year ended 2024-12-31
-50.6%
5-year compound annual growth
-31.6%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $582.0K | +755.9% | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | $68.0K | n/a | 2025-03-12, From 2023-01-01 |
| 2022-12-31 | $0 | n/a | 2024-03-14, From 2022-01-01 |
| No annual figure between 2020-12-31 and 2022-12-31. | |||
| 2020-12-31 | $5.80M | -70.7% | 2021-03-11, From 2020-01-01 |
| 2019-12-31 | $19.81M | -15.1% | 2021-03-11, From 2019-01-01 |
| 2018-12-31 | $23.34M | +9.7% | 2020-03-19, From 2018-01-01 |
| 2017-12-31 | $21.27M | -4.7% | 2019-03-22, From 2017-01-01 |
| 2016-12-31 | $22.31M | -9.0% | 2018-03-09, From 2016-01-01 |
| 2015-12-31 | $24.52M | -5.9% | 2017-03-09, From 2015-01-01 |
| 2014-12-31 | $26.05M | +9.7% | 2016-03-15, From 2014-01-01 |
| 2013-12-31 | $23.75M | -1.3% | 2015-03-27, From 2013-01-01 |
| 2012-12-31 | $24.06M | +0.8% | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | $23.87M | -5.7% | 2013-03-29, From 2011-01-01 |
| 2010-12-31 | $25.31M | n/a | 2012-03-30, From 2010-01-01 |